Melanoma Genomics
- Cancer PHGKB -
What's New
Last Posted: Jan 18, 2019
- The association between dermoscopic features and BRAF mutational status in cutaneous melanoma: Significance of the blue-white veil.
Armengot-Carbó Miquel et al. Journal of the American Academy of Dermatology 2018 78(5) 920-926.e4 - Exploring the Emotional and Behavioural Reactions to Receiving Personalised Melanoma Genomic Risk Information: A Qualitative Study.
Fenton G L et al. The British journal of dermatology 2018 Dec - Current Approaches to Pancreatic Cancer Screening.
Chhoda Ankit et al. The American journal of pathology 2019 Jan 189(1) 22-35 - An 11-gene-based prognostic signature for uveal melanoma metastasis based on gene expression and DNA methylation profile.
Li Yang et al. Journal of cellular biochemistry 2018 Dec - Predictive and on-treatment monitoring biomarkers in advanced melanoma: Moving toward personalized medicine.
Tarhini Ahmad et al. Cancer treatment reviews 2018 Dec 718-18 - Melanoma subtypes: Genomic profiles, prognostic molecular markers and therapeutic possibilities.
Rabbie Roy et al. The Journal of pathology 2018 Dec - Management Decisions Made by Physician Assistants and Nurse Practitioners in Cutaneous Malignant Melanoma Patients: Impact of a 31-Gene Expression Profile Test
Mirsky Rachel et al. Journal of drugs in dermatology : JDD 2018 Nov 17(11) 1220-1223 - FDA approves ‘precision medicine’ drug for different cancers with same mutation
L McGinley, Washington Post, November 26, 2018 - Gene expression profiling in melanoma: past results and future potential.
Knackstedt Rebecca W et al. Future oncology (London, England) 2018 Nov - Molecular Profiling of Cohorts of Tumor Samples to Guide Clinical Development of Pembrolizumab as Monotherapy.
Ayers Mark et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Nov
No hay comentarios:
Publicar un comentario